131 related articles for article (PubMed ID: 1831402)
21. Enhancement by uridine of the anabolism of 5-fluorouracil in mouse T-lymphoma (S-49) cells.
Parker WB; Klubes P
Cancer Res; 1985 Sep; 45(9):4249-56. PubMed ID: 2411399
[TBL] [Abstract][Full Text] [Related]
22. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
Davis ST; Berger SH
Mol Pharmacol; 1989 Apr; 35(4):422-7. PubMed ID: 2523018
[TBL] [Abstract][Full Text] [Related]
23. Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.
Wadler S; Wersto R; Weinberg V; Thompson D; Schwartz EL
Cancer Res; 1990 Sep; 50(18):5735-9. PubMed ID: 1697499
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity.
Longo GS; Izzo J; Chang YM; Tong WP; Zielinski Z; Gorlick R; Chou TC; Bertino JR
Clin Cancer Res; 1998 Feb; 4(2):469-73. PubMed ID: 9516938
[TBL] [Abstract][Full Text] [Related]
25. A study of various strategies to enhance the cytotoxic activity of 5-fluorouracil/leucovorin in human colorectal cancer cell lines.
Scheithauer W; Temsch EM
Anticancer Res; 1989; 9(6):1793-8. PubMed ID: 2627128
[TBL] [Abstract][Full Text] [Related]
26. Dissociation of 5-fluorouracil-induced DNA fragmentation from either its incorporation into DNA or its cytotoxicity in murine T-lymphoma (S-49) cells.
Parker WB; Kennedy KA; Klubes P
Cancer Res; 1987 Feb; 47(4):979-82. PubMed ID: 3802103
[TBL] [Abstract][Full Text] [Related]
27. Search for the optimal schedule for the oxaliplatin/5-fluorouracil association modulated or not by folinic acid: preclinical data.
Fischel JL; Etienne MC; Formento P; Milano G
Clin Cancer Res; 1998 Oct; 4(10):2529-35. PubMed ID: 9796987
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells.
Keyomarsi K; Moran RG
J Biol Chem; 1988 Oct; 263(28):14402-9. PubMed ID: 2971656
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of 5-fluorouracil efficacy by the dihydrouracil dehydrogenase inhibitor, 5-benzyloxybenzyluracil.
Naguib FN; Hao SN; el Kouni MH
Cancer Res; 1994 Oct; 54(19):5166-70. PubMed ID: 7923135
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells.
Smith SG; Lehman NL; Moran RG
Cancer Res; 1993 Dec; 53(23):5697-706. PubMed ID: 8242626
[TBL] [Abstract][Full Text] [Related]
31. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
Waxman S; Scher BM; Hellinger N; Scher W
Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
[TBL] [Abstract][Full Text] [Related]
32. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
Houghton JA; Morton CL; Adkins DA; Rahman A
Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
[TBL] [Abstract][Full Text] [Related]
33. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
34. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
Petak I; Tillman DM; Houghton JA
Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
[TBL] [Abstract][Full Text] [Related]
35. Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate.
Locke JM; Stutchbury TK; Vine KL; Gamble AB; Clingan PR; Bremner JB; Ranson M
Anticancer Drugs; 2009 Oct; 20(9):822-31. PubMed ID: 19606016
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
[TBL] [Abstract][Full Text] [Related]
37. Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cells.
Diasio RB; Schuetz JD; Wallace HJ; Sommadossi JP
Cancer Res; 1985 Oct; 45(10):4900-3. PubMed ID: 3928143
[TBL] [Abstract][Full Text] [Related]
38. A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine alone.
Valone FH; Kohler M; Fisher K; Hannigan J; Flam M; Gandara D; Hendrickson C; Richman E; Yu KP
NCI Monogr; 1987; (5):175-7. PubMed ID: 2963230
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors.
Kogure T; Ueno Y; Iwasaki T; Shimosegawa T
Cancer Chemother Pharmacol; 2004 Apr; 53(4):296-304. PubMed ID: 14689231
[TBL] [Abstract][Full Text] [Related]
40. Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts.
Blumenthal RD; Sharkey RM; Natale AM; Kashi R; Wong G; Goldenberg DM
Cancer Res; 1994 Jan; 54(1):142-51. PubMed ID: 8261435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
